- Home
- MREO vs USIO Comparison
MREO vs USIO Comparison
Compare MREO & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | USIO |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United Kingdom | United States |
| Employees | N/A | 110 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 58.8M |
| IPO Year | 2017 | 1999 |
Fundamental Metrics
Financial Performance| Metric | MREO | USIO |
|---|---|---|
| Price | $0.34 | $2.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $1.50 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.7M | 169.0K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $500,000.00 | ★ $28,200,535.00 |
| Revenue This Year | $5,184.20 | $12.15 |
| Revenue Next Year | $55.51 | $8.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $0.20 | $1.03 |
| 52 Week High | $2.37 | $2.62 |
Technical Indicators
Market Signals| Indicator | MREO | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 57.32 | 60.39 |
| Support Level | $0.29 | $1.36 |
| Resistance Level | $0.36 | $2.62 |
| Average True Range (ATR) | 0.03 | 0.18 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 88.36 | 55.29 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About USIO Usio Inc.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.